Pediatric Acute-Onset Neuropsychiatric Syndrome: A Data Mining Approach to a Very Specific Constellation of Clinical Variables.
Antonella Gagliano, Cecilia Galati, Massimo Ingrassia...
https://pubmed.ncbi.nlm.nih.gov/32460516/Actively Recruiting
Led by University of Cagliari · Updated on 2026-07-31
80
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are investigating Pediatric Acute-onset Neuropsychiatric Syndrome PANS, a complex disorder marked by sudden symptom onset and diagnosed mainly through clinical criteria due to the lack of reliable biomarkers. This study aims to identify neurophysiological, molecular, genetic, and metabolomic markers related to disease onset, progression, and response to treatments such as antimicrobial, anti-inflammatory, and immunomodulatory therapies. Understanding these biomarkers may improve diagnosis, clarify disease mechanisms, and guide more targeted treatments. The study involves detailed clinical and sleep evaluations, including overnight polysomnography and EEG recordings, standardized psychometric assessments, and cognitive testing in children and adolescents diagnosed with PANS. Biological samples will be collected for multi-omics analyses like whole-exome sequencing, microRNA profiling, and metabolomic studies. Additionally, a maternal immune activation animal model will be used to explore causal mechanisms underlying PANS symptoms, combining behavioral, electrophysiological, and molecular assessments. Participants will undergo comprehensive clinical, neurophysiological, genetic, and molecular evaluations over an average of 36 months. Data collected include inflammatory biomarker concentrations, microRNA expression, metabolomic profiles, and genetic variant frequencies. These measurements will be analyzed to identify diagnostic and prognostic biomarkers. Safety and clinical status will be monitored throughout, with repeated assessments to understand disease trajectories and treatment responses.
CONDITIONS
Biomarkers for Diagnosis and Treatment Response in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
M
Monica MF Puligheddu, MD, PHD
A
Antonella Gagliano, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Cagliari
Lead Sponsor
University of Palermo
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 36 months
Participants undergo clinical evaluations, overnight sleep studies including polysomnography and EEG, cognitive testing, and provide blood samples for genetic and molecular analyses.
Multiple visits over study period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Antonella Gagliano, Cecilia Galati, Massimo Ingrassia...
https://pubmed.ncbi.nlm.nih.gov/32460516/Antonella Gagliano, Monica Puligheddu, Nadia Ronzano...
https://pubmed.ncbi.nlm.nih.gov/34326674/Antonella Gagliano, Federica Murgia, Agata Maria Capodiferro...
https://pubmed.ncbi.nlm.nih.gov/36362721/Alessandro Ieraci, Sarah Beggiato, Luca Ferraro...
https://pubmed.ncbi.nlm.nih.gov/32726686/Jennifer Frankovich, Margo Thienemann, Jennifer Pearlstein...
https://pubmed.ncbi.nlm.nih.gov/25695943/Jimmy Zheng, Jennifer Frankovich, Emily S McKenna...
https://pubmed.ncbi.nlm.nih.gov/32364596/Susanne Bejerot, Eva Hesselmark
https://pubmed.ncbi.nlm.nih.gov/30705260/Madeleine W Cunningham
https://pubmed.ncbi.nlm.nih.gov/24892819/Giulia Carini, Jessica Mingardi, Francesco Bolzetta...
https://pubmed.ncbi.nlm.nih.gov/35205276/Antonella Gagliano, Alessandra Carta, Marcello G Tanca...
https://pubmed.ncbi.nlm.nih.gov/37251418/University of Cagliari
Lead Sponsor
University of Palermo
Collaborating Sponsor